Targeted delivery of DNA encoding herpes simplex virus type-1 glycoprotein D enhances the cellular response to primary viral challenge

Archives of Dermatological Research

Volumn 292, Issue 11, 2000, Pages 542-549

  Rogers, James V ^a   Bigley, Nancy J ^a   Chiou, Henry C ^b   Hull, B E ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b Orchestra Therapeutics Inc   (United States)

Author keywords

Asialoorosomucoid; Glycoprotein D; Herpes simplex virus; Vaccine

Indexed keywords

ASIALOOROSOMUCOID; GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DENDRITIC CELL; DNA DETERMINATION; GENE TARGETING; HERPES SIMPLEX VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD45; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION; ASIALOGLYCOPROTEINS; CHEMOKINES, CX3C; CHEMOKINES, CXC; DNA, VIRAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HERPESVIRUS 1, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; OROSOMUCOID; PLASMIDS; POLYLYSINE; S100 PROTEINS; SKIN; TIME FACTORS; VIRAL ENVELOPE PROTEINS; VIRUS DISEASES;

EID: 0034530506     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030000181     Document Type: Article

References (61)

1. The response of Langerhans cells in the cornea to herpetic keratitis
2. A new class of membrane-bound chemokine with CX3C motif
3. The role of macrophages in the pathogenesis of HSV-1 induced chorioretinitis in BALB/c animals
4. DNA immunization against experimental genital herpes simplex virus infection
5. Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus
6. Characterization of human skin-derived CD1a-positive lymph cells
7. Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriers
8. Modulating the immune response to genetic immunization
9. A novel immunization method to induce cytotoxic T lymphocyte responses (CTL) against plasmid-encoded herpes simplex type-1 glycoprotein D
10. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro
11. Evolution of recurrent herpes simplex lesions: An immunohistologic study
12. DNA vaccines
13. Epidermal Langerhans cells, dermal dendritic cells, and keratinocytes in viral lesions of skin and mucous membranes: An immunohistochemical study
14. Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated animals with herpes simplex virus type-1
15. MHC-II but not MHC-I responses are required for vaccine-induced protection against ocular challenge with HSV-1
16. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge
17. The role of neutralizing antibody and T-helper subsets in protection and pathogenesis of vaccinated animals following ocular HSV-1 challenge
18. Vaccination with different HSV-1 glycoproteins induces different patterns of ocular cytokine responses following HSV-1 challenge of vaccinated animals
19. Either a CD4+ or CD8+ T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in animals
20. Mechanisms of herpes simplex virus type 1 reactivation
21. Shedding of herpes simplex virus type 1 into saliva
22. Immune recognition of foreign DNA: A cure for bioterrorism?
23. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions
24. Anti-interleukin-6 antibodies inhibit herpes simplex virus reactivation
25. Nucleic acid vaccine encoding gD2 protects animals from herpes simplex virus type 2 disease
26. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization
27. Role of mucosal immunity in herpes simplex virus infection
28. Biology and molecular aspects of herpes simplex and varicella-zoster virus infections
29. Animals lacking inducible nitric oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses
30. + T lymphocytes
31. Enhancement of immune response to naked DNA vaccines by immunization with transfected dendritic cells
32. Modulation of Langerhans cell phenotype, migration and maturation by agents known to cause herpes simplex virus reactivation in a mouse model
33. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes
34. Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-γ
35. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2
36. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
37. Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is upregulated upon dendritic cell maturation
38. Exposing the immunology of naked DNA vaccines
39. Murine response to DNA encoding herpes simplex virus type-1 glycoprotein D targeted to the liver
40. Herpes simplex virus: Pathogenesis, immunobiology, and control
41. Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins
42. Intrinsic resistance to viral infection, mouse macrophage restriction of herpes simplex virus replication
43. Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease
44. In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 model
45. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viralclearance is dependent upon interferon-γ (IFN-γ)
46. Skin Langerhans cells play an essential role in the defense against HSV-1 infection
47. Herpes simplex virus type 1 pathogenicity in footpad and ear skin of animals depends on Langerhans cell density, mouse genetics, and virus strain
48. Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex virus type 1 (HSV-1) pathogenicity
49. Gene vaccination: Plasmid DNA is more than just a blueprint
50. Immunohistochemical study of cellular events in lesional skin during common virus infections
51. DNA vaccines
52. The role of polymorphonuclear leukocyte infiltration in herpes simplex virus infection of murine skin
53. Immunohistochemical detection of T-cell subsets and other leukocytes in paraffin-embedded rat and mouse tissues with monoclonal antibodies
54. Effects on murine epidermal Langerhans cells of drugs known to cause recrudescent herpes simplex virus infection in a mouse model
55. Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low-density lipoprotein receptor-deficient rabbits
56. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system
57. Receptor-mediated gene delivery and expression in vivo
58. Evidence for targeted gene delivery to Hep G2 hepatoma cells in vitro
59. Receptor-mediated gene delivery in vivo. Partial correction of analbuminemiain nagase rats